NCT04102917 is a clinical trial of QFR assessment in Ischemic Heart Disease, sponsored by Seoul St. Mary's Hospital.

Who is sponsoring NCT04102917?

NCT04102917 is sponsored by Seoul St. Mary's Hospital.

What drugs are being tested in NCT04102917?

Interventions in NCT04102917: QFR assessment.

What condition does NCT04102917 study?

NCT04102917 studies Ischemic Heart Disease.

Is NCT04102917 still recruiting?

NCT04102917 is currently completed. Last updated 25 September 2019.

Last reviewed 2019-09-25 · How we verify

NCT04102917

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Diagnostic Performance and Prognostic Ability of the QFR

Completed Last updated 25 September 2019

What this trial tests

trial testing QFR assessment in Ischemic Heart Disease in 915 participants. Completed in 14 June 2019.

Timeline

1 January 2012

Primary endpoint
31 May 2018

14 June 2019

Quick facts

Lead sponsor	Seoul St. Mary's Hospital
Status	Completed
Study type	OBSERVATIONAL
Enrollment	915
Start date	1 January 2012
Primary completion	31 May 2018
Estimated completion	14 June 2019
Sites	1 location across South Korea

Drugs / interventions tested

QFR assessment

Conditions studied

Ischemic Heart Disease — all drugs for Ischemic Heart Disease →

Sponsor

Seoul St. Mary's Hospital

Who can join

18 and older, any sex, with Ischemic Heart Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

1. The primary technical endpoint was the diagnostic performance of the QFR against the FFR. 2. The primary clinical endpoint was target vessel failure (TVF) between two groups distributed by a QFR cut-off value of 0.8

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Influence of lesion and disease subsets on the diagnostic performance of the quantitative flow ratio in real-world patients.
Lee KY, Hwang BH, Kim MJ, Choo EH, et al · · 2021 · cited 17× · PMID 33542310 · DOI 10.1038/s41598-021-82235-y

Verify or expand the search:

Other trials of QFR assessment

Trials testing the same drug.

NCT03791788 — Multicenter Registry for Angiography-Derived Quantitative Flow Ratio · completed

Other recruiting trials for Ischemic Heart Disease

Currently open trials in the same condition.

NCT07399002 — LONG NAGOMI™ PMCF STUDY · recruiting
NCT07083557 — Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiome · recruiting
NCT06712862 — A Clinical Study of Evaluating Myocardial Viability in Ischemic Heart Disease with Integrated 18F-FDG PET/MR · recruiting
NCT07009418 — Smart Angioplasty Research Team-Coronary CT Angiography Versus Standard Care as Follow-up Strategies in High-Risk Patien · NA · recruiting
NCT06891456 — Pulsed Field Ablation for Post-Infarction Ventricular Tachycardia · NA · recruiting

Other Seoul St. Mary's Hospital trials

Trials by the same sponsor.

NCT07345026 — Acellular Dermal Matrix(SureDerm BCS) in Breast-Conserving Surgery for Breast Cancer Patients · NA · not yet recruiting
NCT07380867 — Confirming the Accuracy of Endoscopic Marking Using a New Marker, a Novel Luminomarker, in Lesion Marking Before Colorec · NA · enrolling by invitation
NCT07240844 — Enavogliflozin for the Management of Patients With Amyloid CardiomyopaThy · Phase 4 · not yet recruiting
NCT06769087 — Comparing Immediate Removal and Postoperative 1 Day of Urinary Catheter After Colorectal Cancer Surgery · NA · enrolling by invitation
NCT06442111 — The Role of Intravenous Ferritin in Optimizing Postoperative Recovery Following Pancreaticoduodenectomy · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04102917 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Seoul St. Mary's Hospital
Last refreshed: 25 September 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04102917.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing